Navigation Links
World class technology and talent battle cancer at the Centenary Institute
Date:11/26/2007

est-ranked papers in biomedicine, we are honoured to have such an eminent researcher as Professor Weninger join the Centenary Institute.

I am confident that the results of his teams research will vastly improve our understanding of how the bodys immune system fights cancer and infectious diseases. The multiphoton microscope will also support the research of other Centenary scientists particularly in autoimmune and liver diseases.

The multiphoton microscope at the Centenary Institute has two unique features, its imaging mode and laser. The unique imaging mode uses multiple laser beams and means fast moving objects and dynamic processes in living tissue can be viewed, for example, cells in the blood stream. The laser has been enhanced with a unit called an OPO that produces longer wavelengths of light than those used in other microscopes enabling researchers to potentially look deeper into living tissue than ever before.


'/>"/>

Contact: Jane Moloney
j.moloney@centenary.org.au
61-295-656-118
Research Australia
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
3. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
4. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
5. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
6. Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention
7. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
8. Depression May Be Worlds Most Disabling Disease
9. Concentra Opens On-Site Medical Unit at World Trade Center Site
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. Womens World Banking Welcomes New Network Member From Tunisia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
... budding youth, who suffer migraine attacks, bewar...n migraine sufferers to be prone// to depression a...ng other psychiatric ailments like panic disorder ...nes are prone to depressive tendencies bordering o...
...s for those who like to eat like squirrels. Pistac...clared heart-friendly by scientists//. Researche... in integrative biosciences at Penn State, perform...eed after a typical American diet which consisted ...
...nown that patients suffering dementia lead a troub...ummets further if they lead uninteresting lives. A...ited Kingdom and most of them live in solitary con...ch patients; lack of mental stimulation, social ac...
...tic fields do not pose a health hazard to workers ... a large study of 28,000 people, published ahead o...ne. Exposure to low frequency electromagnetic fie... implicated in an increased risk of leukemia, brai...
Other Medicine News:Health News:Link Between Migraine Attacks in Teens and Suicidal Tendencies 2Health News:Pistachio Nuts Keep Away Heart Diseases 2Health News:Dementia – Worse With a Dull Life. Keep Busy, and Active to Improve Memory, Study Recommend 2
(Date:9/4/2008)... Updated Survival Data for Ipilimumab...swire-FirstCall/ -- Medarex, Inc.,(Nasdaq: MEDX )...ipilimumab,an investigational anti-CTLA-4 antibod...presentations at the 33rd Congress of the European...ptember 12-16, 2008 in Stockholm.,Many of the foll...
(Date:9/4/2008)... Data Announcements Remain on Schedule with Tw...ge Clinical Data Release in November 2008, BRIDGE...maceuticals,Inc., a specialty pharmaceutical comp... metabolic disease, today announced the appointmen...rd of directors., Peter Garrambone,s career inclu...
(Date:9/3/2008)... NANJING, China, Sept. 3 /PRNewswire-FirstCal...a leading manufacturer and supplier of,branded gen...ted,anti-cancer biotech product Endu (also known a...s of Endu Phase IV clinical study., At the reques...al study,to further validate the safety and therap...
(Date:9/3/2008)... September is National Vascular Diseas.../- Diffusion Pharmaceuticals,LLC, a c...zing new drugs,for the treatment of unmet medical ... patients in a Phase I/II clinical trial of its le...The trial, designated NCT00725881,on the clinicalt...
Breaking Medicine Technology:Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle 9131 1New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle 9131 2New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle 9131 3Mini stress tests could help condition heart to survive major attack 9128 1Mini stress tests could help condition heart to survive major attack 9128 2WuXi PharmaTech 28NYSE 3A WX 29 Names Temporary Chairman of the Audit Committee 9125 1WuXi PharmaTech 28NYSE 3A WX 29 Names Temporary Chairman of the Audit Committee 9125 2Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers 1787 1Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers 1787 2
...lects Continued Growth of Eisai,s,Commitment to On...wire/ -- Eisai,announced today that several abstra...peline compounds have been accepted for,presentati...SCO),annual meeting. ASCO takes place in Chicago f...wing and diverse oncology clinical,development pro...
... Phase II data from XL999 studies,scheduled for pr...AN FRANCISCO, May 30, 2007 /PRNewswire-FirstCall/ ...linical trials of,the company,s investigational co...007 American Society of Clinical Oncology Annual,M...Chicago,Illinois. , , -- Data from the Phase I...
Other Medicine Technology:Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 2Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 3Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 4Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: